Genprex Launch IPO For Trials Of New Gene Therapy Lung Cancer TreatmentBlog
RodTurner's blog Prospectus. Genprex is raising capital through their S-1 IPO offering with the intent to complete their IPO and list on the Nasdaq Exchange under the ticker NASDAQ: GNPX. The offering is for $6.5 ...